Skip to main content
Log in

Methyl-CpG-Binding Domain Protein 3 Promotes Seizures by Recruiting Methyltransferase DNMT1 to Enhance TREM2 Methylation

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Epilepsy represents a hazardous neurological disorder, underpinned by a pathophysiological process that is yet to be fully understood. Here, we aimed to elucidate the effect of methyl-CpG-binding domain protein 3 (MBD3) on hippocampal neuronal damage in epileptic mice by targeting the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway. The expression of MBD3 was determined by Western blot in a hippocampal neuronal culture (HNC) epileptic model established using the low Mg2+ECF culture method. The interaction between MBD3 and DNA methyltransferase 1 (DNMT1) was determined via co-immunoprecipitation and mass spectrometry analysis. Bisulfite modification and sequencing was performed to evaluate the degree of methylation of triggering receptor expressed on myeloid cells 2 (TREM2). The viability and apoptosis of hippocampal neurons were detected by CCK-8 and TUNEL assays, respectively. Finally, the effect of MBD3 was verified in vivo. MBD3 was highly expressed in the HNC model of epilepsy, with its interaction with DNMT1 found to promote the hypermethylation of TREM2 at site cg25748868. Additionally, decreased TREM2 and inhibited PI3K/Akt pathway was observed in the HNC epileptic model. Simultaneous inhibition of MBD3 and DNMT1 decreased the methylation level at cg25748868, up-regulated TREM2 expression, and activated the PI3K/Akt pathway, thereby arresting neuronal damage. Inhibition of MBD3 reduced the level of epileptic seizures, down-regulated cg25748868 methylation, activated TREM2-mediated signaling pathways, and alleviated hippocampal neuronal damage in the acute seizure mouse models. The present study unveiled that MBD3 and DNMT1 synergistically enhanced hypermethylation of cg25748868 in TREM2, and promoted the onset of epilepsy via inhibition of the PI3K/Akt pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data Availability

The datasets supporting the conclusions of this article are available.

References

  1. Johnson EL (2019) Seizures and epilepsy. Med Clin North Am 103(2):309–324

    Article  Google Scholar 

  2. Moshe SL, Perucca E, Ryvlin P et al (2015) Epilepsy: new advances. Lancet 385(9971):884–898

    Article  Google Scholar 

  3. Devinsky O, Vezzani A, O’Brien TJ et al (2018) Epilepsy. Nat Rev Dis Primers 4:18024

    Article  Google Scholar 

  4. Thijs RD, Surges R, O’Brien TJ et al (2019) Epilepsy in adults. Lancet 393(10172):689–701

    Article  Google Scholar 

  5. Loscher W, Klitgaard H, Twyman RE et al (2013) New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 12(10):757–776

    Article  Google Scholar 

  6. Oto MM (2017) The misdiagnosis of epilepsy: appraising risks and managing uncertainty. Seizure 44:143–146

    Article  Google Scholar 

  7. Du Q, Luu PL, Stirzaker C et al (2015) Methyl-CpG-binding domain proteins: readers of the epigenome. Epigenomics 7(6):1051–1073

    Article  CAS  Google Scholar 

  8. Leighton G, Williams DC (2019) The methyl-CpG-binding domain 2 and 3 proteins and formation of the nucleosome remodeling and deacetylase complex. J Mol Biol 432(6):1624–1639

    Article  Google Scholar 

  9. Bednarczyk J, Debski KJ, Bot AM et al (2016) MBD3 expression and DNA binding patterns are altered in a rat model of temporal lobe epilepsy. Sci Rep 6:33736

    Article  CAS  Google Scholar 

  10. Cai Y, Geutjes EJ, de Lint K et al (2014) The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes. Oncogene 33(17):2157–2168

    Article  CAS  Google Scholar 

  11. Kobow K, Kaspi A, Harikrishnan KN et al (2013) Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol 126(5):741–756

    Article  CAS  Google Scholar 

  12. Jin SC, Benitez BA, Karch CM et al (2014) Coding variants in TREM2 increase risk for Alzheimer’s disease. Hum Mol Genet 23(21):5838–5846

    Article  CAS  Google Scholar 

  13. Jonsson T, Stefansson H, Steinberg S et al (2013) Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med 368(2):107–116

    Article  CAS  Google Scholar 

  14. Kawabori M, Kacimi R, Kauppinen T et al (2015) Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J Neurosci 35(8):3384–3396

    Article  CAS  Google Scholar 

  15. Liu AH, Chu M, Wang YP (2019) Up-regulation of Trem2 inhibits hippocampal neuronal apoptosis and alleviates oxidative stress in epilepsy via the PI3K/Akt pathway in mice. Neurosci Bull 35(3):471–485

    Article  CAS  Google Scholar 

  16. Lunnon K, Smith R, Hannon E et al (2014) Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer’s disease. Nat Neurosci 17(9):1164–1170

    Article  CAS  Google Scholar 

  17. Smith AR, Smith RG, Condliffe D et al (2016) Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer’s disease brain. Neurobiol Aging 47:35–40

    Article  CAS  Google Scholar 

  18. Xie N, Wang C, Wu C et al (2016) Mdivi-1 protects epileptic hippocampal neurons from apoptosis via inhibiting oxidative stress and endoplasmic reticulum stress in vitro. Neurochem Res 41(6):1335–1342

    Article  CAS  Google Scholar 

  19. Srinivasan S, Stevens M, Wiley JW (2000) Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49(11):1932–1938

    Article  CAS  Google Scholar 

  20. Ma DL, Qu JQ, Goh EL et al (2015) Reorganization of basolateral amygdala-subiculum circuitry in mouse epilepsy model. Front Neuroanat 9:167

    PubMed  Google Scholar 

  21. Chatzikonstantinou A (2014) Epilepsy and the hippocampus. Front Neurol Neurosci 34:121–142

    Article  Google Scholar 

  22. Pitkanen A, Loscher W, Vezzani A et al (2016) Advances in the development of biomarkers for epilepsy. Lancet Neurol 15(8):843–856

    Article  CAS  Google Scholar 

  23. Shetty AK (2014) Hippocampal injury-induced cognitive and mood dysfunction, altered neurogenesis, and epilepsy: can early neural stem cell grafting intervention provide protection? Epilepsy Behav 38:117–124

    Article  Google Scholar 

  24. Kobow K, Blumcke I (2014) Epigenetic mechanisms in epilepsy. Prog Brain Res 213:279–316

    Article  Google Scholar 

  25. Unnikrishnan A, Freeman WM, Jackson J et al (2019) The role of DNA methylation in epigenetics of aging. Pharmacol Ther 195:172–185

    Article  CAS  Google Scholar 

  26. Greenberg MVC, Bourc’his D (2019) The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol 20(10):590–607

    Article  CAS  Google Scholar 

  27. Qureshi IA, Mehler MF (2010) Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis 39(1):53–60

    Article  CAS  Google Scholar 

  28. Zhu Q, Wang L, Zhang Y et al (2012) Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy. J Mol Neurosci 46(2):420–426

    Article  CAS  Google Scholar 

  29. de Nijs L, Choe K, Steinbusch H et al (2019) DNA methyltransferase isoforms expression in the temporal lobe of epilepsy patients with a history of febrile seizures. Clin Epigenetics 11(1):118

    Article  Google Scholar 

  30. Lin N, Qin S, Luo S et al (2014) Homocysteine induces cytotoxicity and proliferation inhibition in neural stem cells via DNA methylation in vitro. FEBS J 281(8):2088–2096

    Article  CAS  Google Scholar 

  31. Becker AJ (2018) Review: animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis. Neuropathol Appl Neurobiol 44(1):112–129

    Article  CAS  Google Scholar 

  32. Liu K, Lei M, Wu Z et al (2019) Structural analyses reveal that MBD3 is a methylated CG binder. FEBS J 286(16):3240–3254

    Article  CAS  Google Scholar 

  33. Stefaniuk M, Lukasiuk K (2010) Cloning of expressed sequence tags (ESTs) representing putative epileptogenesis-related genes and the localization of their expression in the normal brain. Neurosci Lett 482(3):230–234

    Article  CAS  Google Scholar 

  34. Painter MM, Atagi Y, Liu CC et al (2015) TREM2 in CNS homeostasis and neurodegenerative disease. Mol Neurodegener 10:43

    Article  Google Scholar 

  35. Mecca C, Giambanco I, Donato R et al (2018) Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes. Int J Mol Sci 19(1):318

    Article  Google Scholar 

  36. Xu P, Zhang X, Liu Q et al (2019) Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke. Cell Death Dis 10(8):555

    Article  Google Scholar 

  37. Wu R, Li X, Xu P et al (2017) TREM2 protects against cerebral ischemia/reperfusion injury. Mol Brain 10(1):20

    Article  Google Scholar 

  38. Li C, Zhao B, Lin C et al (2019) TREM2 inhibits inflammatory responses in mouse microglia by suppressing the PI3K/NF-kappaB signaling. Cell Biol Int 43(4):360–372

    Article  CAS  Google Scholar 

  39. Davies MA (2012) The role of the PI3K-AKT pathway in melanoma. Cancer J 18(2):142–147

    Article  CAS  Google Scholar 

  40. Kretz A, Happold CJ, Marticke JK et al (2005) Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci 29(4):569–579

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the reviewers for their helpful comments on this paper.

Funding

This work was supported by Research and Innovation Fund of Harbin Medical University (No. 2020L06), National Natural Science Foundation of China (Nos. 81601130 & 81772678), and Foundation of Heilongjiang Health and Family Planning Commission (No. 2018375).

Author information

Authors and Affiliations

Authors

Contributions

MN and HYW designed the study. WZ, ZBH and SKY collated the data, carried out data analyses and produced the initial draft of the manuscript. YMF and JYS revised the figures and tables. YFG, XBC, and ZGL contributed to drafting the manuscript. All authors have read and approved the final submitted manuscript.

Corresponding author

Correspondence to Meng Na.

Ethics declarations

Conflict of interest

The authors declare no actual or potential conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

11064_2021_3371_MOESM1_ESM.eps

Supplementary file1 Validation of the HNC model by the whole-cell patch clamp technology. Note: in the presence of 300 mmol/L CRS, the whole-cell patch clamp technique was used to measure the current of normal cells and modeled cells for 15 min and the electricity was recorded. (EPS 1158 kb)

Supplementary file2 (DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Feng, Y., Sun, J. et al. Methyl-CpG-Binding Domain Protein 3 Promotes Seizures by Recruiting Methyltransferase DNMT1 to Enhance TREM2 Methylation. Neurochem Res 46, 2451–2462 (2021). https://doi.org/10.1007/s11064-021-03371-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-021-03371-5

Keywords

Navigation